Nephrol Dial Transplant (2003) 18: 426-428
© 2003 European Renal Association-European Dialysis and Transplant Association
Case Report
Invasive urothelial carcinoma after exposure to Chinese herbal medicine containing aristolochic acid may occur without severe renal failure
1 Department of Nephrology, 2 Department of Stomatology and 3 Department of Pathology, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium, 4 Division of Molecular Toxicology, German Cancer Research Center, Heidelberg, Germany and 5 Institute of Cancer Research, Haddow Laboratories, Sutton, UK
Keywords: Aristolochia fangchi; aristolochic acid; carcinogenicity; Chinese-herb nephropathy; DNA adducts; herbal remedies
| The first 10% of the full text of this article appears below. |
| Introduction |
|---|
Chinese-herb nephropathy (CHN) was initially reported as a progressive renal interstitial fibrosis caused by the regular intake of Chinese herbal medicine belonging to the Aristolochia species containing nephrotoxic and carcinogenic aristolochic acid (AA) [13]. Prior exposure to AA was attested by the detection of specific DNA adducts formed by AA metabolites in kidneys and ureters of patients suffering from end-stage renal disease (ESRD) due to CHN [46]. Among these patients, a high prevalence of upper urinary tract carcinoma was observed [5,7].
| Case |
|---|
| Discussion |
|---|
This article has been cited by other articles:
![]() |
X. Xue, Y. Xiao, H. Zhu, H. Wang, Y. Liu, T. Xie, and J. Ren Induction of P450 1A by 3-methylcholanthrene protects mice from aristolochic acid-I-induced acute renal injury Nephrol. Dial. Transplant., October 1, 2008; 23(10): 3074 - 3081. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Arlt, M. Stiborova, J. vom Brocke, M. L. Simoes, G. M. Lord, J. L. Nortier, M. Hollstein, D. H. Phillips, and H. H. Schmeiser Aristolochic acid mutagenesis: molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer Carcinogenesis, November 1, 2007; 28(11): 2253 - 2261. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Nortier and J.-L. Vanherweghem For patients taking herbal therapy--lessons from aristolochic acid nephropathy Nephrol. Dial. Transplant., June 1, 2007; 22(6): 1512 - 1517. [Full Text] [PDF] |
||||
![]() |
M. Cui, Z.-H. Liu, Q. Qiu, H. Li, and L.-S. Li Tumour induction in rats following exposure to short-term high dose aristolochic acid I Mutagenesis, January 1, 2005; 20(1): 45 - 49. [Abstract] [Full Text] [PDF] |
||||


